Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

467 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone.
Gómez-Revuelta M, Pelayo-Terán JM, Juncal-Ruiz M, Vázquez-Bourgon J, Suárez-Pinilla P, Romero-Jiménez R, Setién Suero E, Ayesa-Arriola R, Crespo-Facorro B. Gómez-Revuelta M, et al. Int J Neuropsychopharmacol. 2020 Apr 23;23(4):217-229. doi: 10.1093/ijnp/pyaa004. Int J Neuropsychopharmacol. 2020. PMID: 31974576 Free PMC article. Clinical Trial.
Reduced thalamic volume in first-episode non-affective psychosis: correlations with clinical variables, symptomatology and cognitive functioning.
Crespo-Facorro B, Roiz-Santiáñez R, Pelayo-Terán JM, Rodríguez-Sánchez JM, Pérez-Iglesias R, González-Blanch C, Tordesillas-Gutiérrez D, González-Mandly A, Díez C, Magnotta VA, Andreasen NC, Vázquez-Barquero JL. Crespo-Facorro B, et al. Neuroimage. 2007 May 1;35(4):1613-23. doi: 10.1016/j.neuroimage.2007.01.048. Epub 2007 Feb 13. Neuroimage. 2007. PMID: 17395492
Low-activity allele of Catechol-O-Methyltransferase (COMTL) is associated with increased lateral ventricles in patients with first episode non-affective psychosis.
Crespo-Facorro B, Roiz-Santiáñez R, Pelayo-Terán JM, Pérez-Iglesias R, Carrasco-Marín E, Mata I, González-Mandly A, Jorge R, Vázquez-Barquero JL. Crespo-Facorro B, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Oct 1;31(7):1514-8. doi: 10.1016/j.pnpbp.2007.07.011. Epub 2007 Jul 18. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17706335
A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
Perez-Iglesias R, Crespo-Facorro B, Amado JA, Garcia-Unzueta MT, Ramirez-Bonilla ML, Gonzalez-Blanch C, Martinez-Garcia O, Vazquez-Barquero JL. Perez-Iglesias R, et al. J Clin Psychiatry. 2007 Nov;68(11):1733-40. doi: 10.4088/jcp.v68n1113. J Clin Psychiatry. 2007. PMID: 18052567 Clinical Trial.
Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: findings of a randomized clinical trial in a drug-naïve population.
Perez-Iglesias R, Crespo-Facorro B, Martinez-Garcia O, Ramirez-Bonilla ML, Alvarez-Jimenez M, Pelayo-Teran JM, Garcia-Unzueta MT, Amado JA, Vazquez-Barquero JL. Perez-Iglesias R, et al. Schizophr Res. 2008 Feb;99(1-3):13-22. doi: 10.1016/j.schres.2007.10.022. Epub 2007 Dec 3. Schizophr Res. 2008. PMID: 18053689 Clinical Trial.
467 results